Key statistics
On Friday, Evotec SE (EVTA:DUS) closed at 2.92, 22.69% above the 52 week low of 2.38 set on Dec 19, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 2.90 |
|---|---|
| High | 2.92 |
| Low | 2.90 |
| Bid | 2.84 |
| Offer | 3.12 |
| Previous close | 2.92 |
| Average volume | 100.00 |
|---|---|
| Shares outstanding | 355.76m |
| Free float | 316.06m |
| P/E (TTM) | -- |
| Market cap | 1.28bn USD |
| EPS (TTM) | -0.5272 USD |
Data delayed at least 15 minutes, as of Feb 06 2026 18:31 GMT.
More ▼
Announcements
- EQS-DD: Evotec SE: Dr. Cord Dohrmann, Disposal of 3653 shares (Sell-to-cover)
- EQS-DD: Evotec SE: Dr. Cord Dohrmann, Acquisition of 6760 shares due to vesting (Share Performance Plan 2017)
- EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-News: Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
More ▼
